The Current Ratio as of December 2024 (TTM) for Cue Biopharma, Inc. (CUE) is 2.22

According to Cue Biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.22. This represents a change of -9.06% compared to the average of 2.44 of the last 4 quarters.

Cue Biopharma, Inc. (CUE) Historical Current Ratio (quarterly & annually)

How has CUE Current Ratio performed in the past?

The mean historical Current Ratio of Cue Biopharma, Inc. over the last ten years is 8.62. The current 2.22 Current Ratio has changed 2.48% with respect to the historical average. Over the past ten years (40 quarters), CUE's Current Ratio was at its highest in in the June 2018 quarter at 16.62. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Cue Biopharma, Inc. (CUE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cue Biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cue Biopharma, Inc. (CUE) Average Current Ratio

How has CUE Current Ratio performed in the past?

The current Current Ratio of Cue Biopharma, Inc. (CUE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cue Biopharma, Inc. (CUE) Current Ratio vs. Peers

How is CUE’s Current Ratio compared to its peers?

Cue Biopharma, Inc.’s Current Ratio is less than Coya Therapeutics, Inc. (15.31), less than Lantern Pharma Inc. (8.31), less than Fennec Pharmaceuticals Inc. (7.80), less than Eliem Therapeutics, Inc. (0), less than Anixa Biosciences, Inc. (11.31), less than INmune Bio, Inc. (2.59), greater than IN8bio, Inc. (1.84), greater than PolyPid Ltd. (1.00), less than X4 Pharmaceuticals, Inc. (4.89), less than Galera Therapeutics, Inc. (9.74), less than Terns Pharmaceuticals, Inc. (32.99), less than Day One Biopharmaceuticals, Inc. (14.62), less than HOOKIPA Pharma Inc. (3.26), greater than Cognition Therapeutics, Inc. (2.11), greater than TFF Pharmaceuticals, Inc. (0.89), less than TScan Therapeutics, Inc. (9.56), less than Dermata Therapeutics, Inc. (3.44),

Build a custom stock screener for Cue Biopharma, Inc. (CUE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cue Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cue Biopharma, Inc. (CUE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cue Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.